secwatch.observer — SEC 8-K summary
======================================

Issuer:     LivaNova PLC (LIVN)
CIK:        0001639691
Form:       8-K
Filed at:   2024-02-05T23:59:59+00:00
Accession:  0001639691-24-000013
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LivaNova appoints Vladimir Makatsaria as CEO effective March 1, 2024; Kozy remains Chair
--------------------------------------------------------------------------------

- Vladimir Makatsaria, former J&J MedTech Ethicon head, named CEO and Board member effective March 1, 2024.
- Makatsaria receives annual base salary of $930,000, target bonus of 110% of base, and LTI grants totaling $6.85M.
- Interim CEO William Kozy steps down as CEO on March 1 but continues as Board Chair.
- Employment agreement includes sign-on cash bonus of $200,000 and relocation benefits from NYC to Houston.
- Makatsaria holds BA in Physiology, MBA and MHA from University of Minnesota.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1639691/000163969124000013/0001639691-24-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1639691/000163969124000013/livn-20240201.htm
  HTML page:      https://secwatch.observer/filing/0001639691-24-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer